For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), ...

Results of a study comparing apixaban with low-molecular-weight heparin as a treatment to prevent recurrent blood clots in patients with cancer may assuage some of the concern about the bleeding risk ...

Please provide your email address to receive an email when new articles are posted on . Direct oral anticoagulants showed greater efficacy and cost-effectiveness than low-molecular-weight heparin for ...

The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related ...

Therapeutic-dose heparin appears to benefit noncritically-ill COVID-19 patients, but it does not reduce deaths or other adverse endpoints compared with usual-care thromboprophylaxis if it’s initiated ...

Direct oral anticoagulants (DOACs) are more clinically effective and are more cost-effective for treating patients with cancer-associated thrombosis (CAT) in comparison with low-molecular-weight ...

September 12, 2022 – The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent ...

For cancer patients with thromboembolism, the direct oral anticoagulant apixaban (Eliquis; Bristol-Myers Squibb) is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrence of ...

Heparin injectable solution only comes as a generic drug. It doesn’t have a brand-name version. Heparin comes in two forms. One is an injectable solution, which you inject under your skin. The other ...

Apixaban is a direct oral anticoagulant that relies less on kidney excretion. Compared with warfarin, apixaban may lower the risks of recurrent venous thromboembolism (VTE) and major bleeding in ...